Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56<sup>dim</sup>CD16<sup>bright</sup> natural killer cells during kidney allograft antibody-mediated rejection showing a new link between adaptive and innate humoral allo-immunity.
白介素-21促進腎移植物抗體介導排斥期間CD56<sup>dim</sup>CD16<sup>bright</sup>自然殺傷細胞的1型活化和細胞毒性,顯示適應性和固有體液免疫之間的新聯繫。
Kidney Int 2023-10-03
Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry.
腎移植接受者合併 COVID-19 的免疫抑制治療管理:來自西班牙腎臟學會 COVID 註冊資料庫的多中心國家研究。
Nefrologia (Engl Ed) 2024-01-30
Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts.
人類腎移植物RNA定序解讀慢性活躍抗體介導排斥的轉錄組特徵。
Kidney Int 2024-02-27
Back to the future: the uncharted role of T cells in chronic and unexplained microvascular inflammation.
回到未來:T細胞在慢性和未明微血管炎症中的未知角色。
Kidney Int 2024-03-25
High-dimensional Mass Cytometry identified circulating Natural Killer T-cell subsets associated with protection from Cytomegalovirus infection in kidney transplant recipients.
高維度質譜細胞學識別出與腎移植接受者中對巨細胞病毒感染保護相關的循環天然殺傷T細胞亞群。
Kidney Int 2024-04-30
Allogeneic CD4 T Cells Sustain Effective BK Polyomavirus-Specific CD8 T Cell Response in Kidney Transplant Recipients.
異體 CD4 T 細胞維持腎臟移植受者中有效的 BK Polyomavirus 特異性 CD8 T 細胞反應。
Kidney Int Rep 2024-08-19